[PDF][PDF] Acetazolamide challenge and technetium-99m-ECD versus iodine-123-IMP SPECT in chronic occlusive cerebrovascular disease

T Ohnishi, T Yano, S Nakano, S Jinnouchi… - Journal of Nuclear …, 1997 - Soc Nuclear Med
Acetazolamide Challenge and Technetium-99m-ECD Versus Iodine-123-IMP SPECT in
Chronic Occlusive Cerebrovascular Disease Page 1 Acetazolamide Challenge and …

[PDF][PDF] Split dose iodine-123-IMP SPECT: sequential quantitative regional cerebral blood flow change with pharmacological intervention

K Hashikawa, M Matsumoto, H Moriwaki… - Journal of Nuclear …, 1994 - Soc Nuclear Med
A totalof 42 patientswithischemicCVDdiseasewere inves tigated (Table 1). In a
preliminarystudy to determinethe param eters of the regression line, 11 patients with mild …

Error analysis of measured cerebral vascular response to acetazolamide stress by I-123-IMP autoradiographic method with single photon emission computed …

H Ito, K Inoue, R Goto, S Kinomura, T Sato… - Annals of nuclear …, 2004 - Springer
Abstract Objectives: Iodine-123 (123 I)-labeled N-isopropyl-p-iodoamphetamine (IMP) has
been used as a cerebral blood flow (CBF) tracer for single-photon emission computed …

Evaluation of delayed appearance of acetazolamide effect in patients with chronic cerebrovascular ischemic disease: feasibility and usefulness of SPECT method …

M Murakami, T Yonehara, A Takaki… - Journal of Nuclear …, 2002 - Soc Nuclear Med
The purpose of this study was to verify the feasibility and usefulness of a new SPECT
method, called triple injection of 99mTc-ethylcysteinate dimer (TIE), in evaluation of the …

99mTc-HMPAO-SPECT with acetazolamide challenge to detect hemodynamic compromise in occlusive cerebrovascular disease.

J Knop, A Thie, C Fuchs, G Siepmann, H Zeumer - Stroke, 1992 - Am Heart Assoc
Insufficiency of collateral supply may lead to low-flow infarcts in severe occlusive
cerebrovascular disease. The aim of this study was to evaluate the feasibility of technetium …

A study of acetazolamide-induced changes in cerebral blood flow using99mTc HMPAO SPECT in patients with cerebrovascular disease

S Asenbaum, A Reinprecht, T Brücke, S Wenger… - Neuroradiology, 1995 - Springer
For semiquantification of SPECT studies we tried to calculate cerebral 99m Tc-HMPAO
uptake related to injected dose and estimated brain volume. The method was applied to …

SPECT evaluation of brain perfusion reserve by the acetazolamide test using Tc-99m HMPAO

H MATSUDA, S HIGASHI, K KINUYA… - Clinical Nuclear …, 1991 - journals.lww.com
This report describes a new approach to the evaluation of brain perfusion reserve using Tc-
99m HMPAO SPECT. Consecutive brain Tc-99m HMPAO SPECT studies before and after …

[PDF][PDF] Iodine-123-iomazenil and iodine-123-lodoamphetamine SPECT in major cerebral artery occlusive disease

H Moriwaki, M Matsumoto, K Hashikawa… - Journal of Nuclear …, 1998 - Soc Nuclear Med
First Department of Internal Medicine, Department of Neurology, and Division of Nuclear
Medicine, Department of Tracer Kinetics, Osaka University Medical School, Suita, Japan …

Increased brain retention of Tc-99m HMPAO following acetazolamide administration

RW BURT, RM WITT, D CIKRIT… - Clinical nuclear …, 1991 - journals.lww.com
Sixty-five patients rferred for Tc-99m HMPAO SPECT brain perfusion studies had
measurements of global Tc-99m HMPAO retention after injection at rest and after …

Dual-isotope brain SPECT imaging with technetium-99m and iodine-123: clinical validation using xenon-133 SPECT.

MD Devous Sr, JK Payne, JL Lowe - Journal of Nuclear Medicine …, 1992 - europepmc.org
Our phantom studies indicate that the energy resolution (9.7% FWHM) of a new three-
headed single-photon tomograph (PRISM-3000) separates the distribution of 99mTc from …